Proregenerative Activity of IL-33 in Gastric Tissue Cells Undergoing Helicobacter Pylori-Induced Apoptosis
| dc.contributor.author | Chmiela, Magdalena | |
| dc.contributor.author | Gonciarz, Weronika | |
| dc.contributor.author | Krupa, Agnieszka | |
| dc.date.accessioned | 2021-09-10T11:51:49Z | |
| dc.date.available | 2021-09-10T11:51:49Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Gonciarz, W.; Krupa, A.; Chmiela, M. Proregenerative Activity of IL-33 in Gastric Tissue Cells Undergoing Helicobacter Pylori-Induced Apoptosis. Int. J. Mol. Sci. 2020, 21, 1801. https://doi.org/10.3390/ijms21051801 | pl_PL |
| dc.identifier.issn | 1422-0067 | |
| dc.identifier.uri | http://hdl.handle.net/11089/39024 | |
| dc.description.abstract | : Interleukin (IL)-33 is a proinflammatory mediator that alerts the host immune system to disorders in tissue homeostasis. Aim. To understand the role of IL-33 in modulating gastric tissue cell growth affected by Helicobacter pylori (H. pylori). Methods. IL-33 production in guinea pigs (Caviae porcellus) experimentally infected with H. pylori was evaluated by ELISA or immunohistochemical staining. The proregenerative activity of IL-33 was evaluated using gastric epithelial cells and fibroblasts that were naive or transfected with IL-33 siRNA exposed to H. pylori glycine acid extract antigenic complex (GE), as well as by measuring cell migration, proliferation, metabolic activity and apoptosis. Animals infected by H. pylori responded with increased production of IL-33. Also, cells treated in vitro with GE released more IL-33 than cells that were unstimulated. Silencing IL-33 in cells resulted in downregulation of metabolic activity, adhesion, migration and proliferation, especially after treatment with H. pylori GE, as well as upregulation of cells apoptosis associated with caspase 3 increase and Bcl-xL decrease, suggesting proregenerative activity of IL-33. Interestingly, upregulation of cell proliferation by IL-33 was Erk independent. Our results indicate that IL-33 may protect gastric tissue from loss of homeostasis caused by deleterious effects of H. pylori components and the inflammatory response developed during infection. | pl_PL |
| dc.language.iso | en | pl_PL |
| dc.publisher | MDPI | pl_PL |
| dc.relation.ispartofseries | International Journal of Molecular Sciences;21, 1801 | |
| dc.rights | Uznanie autorstwa 4.0 Międzynarodowe | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Helicobacter pylori | pl_PL |
| dc.subject | gastric barrier | pl_PL |
| dc.subject | IL-33 | pl_PL |
| dc.subject | proliferation | pl_PL |
| dc.subject | apoptosis | pl_PL |
| dc.title | Proregenerative Activity of IL-33 in Gastric Tissue Cells Undergoing Helicobacter Pylori-Induced Apoptosis | pl_PL |
| dc.type | Article | pl_PL |
| dc.page.number | 20 | pl_PL |
| dc.contributor.authorAffiliation | Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland | pl_PL |
| dc.contributor.authorAffiliation | Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland | pl_PL |
| dc.contributor.authorAffiliation | Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland | pl_PL |
| dc.references | Tarnawski, A. Cellular and molecular mechanisms of mucosal defense and repair. In Bioregulation and Its Disorders in Gastrointestinal, Tract ed.; Blackwell Science: Japan, Tokyo, 1998; Volume 3, p. 17. | pl_PL |
| dc.references | Terrés, A.M.; Pajares, J.M.; Hopkins, A.M.; Murphy, A.; Moran, A.; Baird, A.W.; Kelleher, D. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun. 1998, 66, 2943–2950. | pl_PL |
| dc.references | Tarnawski, A.S.; Ahluwalia, A.; Jones, M.K. The mechanisms of gastric mucosal injury: Focus on microvascular endothelium as a key target. Curr. Med. Chem. 2012, 19, 4–15. | pl_PL |
| dc.references | Laine, L.; Takeuchi, K.; Tarnawski, A. Gastric mucosal defense and cytoprotection: Bench to bedside. Gastroenterology 2008, 135, 41–60. | pl_PL |
| dc.references | Henriksnäs, J.; Phillipson, M.; Storm, M.; Engstrand, L.; Soleimani, M.; Holm, L. Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G396–G403. | pl_PL |
| dc.references | Goh, K.L.; Chan, W.K.; Shiota, S.; Yamaoka, Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011, 16 (Suppl. S1), 1–9. | pl_PL |
| dc.references | Blaser, M.J.; Atherton, J.C. Helicobacter infection persistence: Biology and disease. J. Clin. Investig. 2004, 113, 321–333. | pl_PL |
| dc.references | Chmiela, M.; Michetti, P. Inflammation, immunity, vaccines for Helicobacter infection. Helicobacter 2006, 11 (Suppl. S1), 21–26. | pl_PL |
| dc.references | Peek, R.M.; Crabtree, J.M.H. H. pylori infection and gastric neoplasia. J. Pathol. 2006, 208, 233–248. | pl_PL |
| dc.references | Posselt, G.; Backert, S.; Wessler, S. The functional interplay of H. pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun. Signal 2013, 11, 77. | pl_PL |
| dc.references | Suzuki, N.; Murata-Kamiya, N.; Yanagiya, K.; Suda, W.; Hattori, M.; Kanda, H.; Bingo, A.; Fujii, Y.; Maeda, S.; Koike, K.; et al. Mutual reinforcement of inflammation and carcinogenesis by the H. pylori CagA oncoprotein. Sci. Rep. 2015, 5, 10024. | pl_PL |
| dc.references | Chmiela, M.; Karwowska, Z.; Gonciarz, W.; Allushi, B.; St ˛aczek, P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J. Gastroenterol. 2017, 23, 1521–1540. | pl_PL |
| dc.references | Rudnicka, K.; Backert, S.; Chmiela, M. Genetic polymorphisms in inflammatory and other regulators in gastric cancer: Risks and clinical consequences. Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. Curr. Top. Microbiol. Immunol. 2019, 421. | pl_PL |
| dc.references | Kusters, J.G.; van Vliet, A.H.; Kuipers, E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19, 449–490. | pl_PL |
| dc.references | Chmiela, M.; Kupcinskas, J. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2019, 24 (Suppl. S1), e12638. | pl_PL |
| dc.references | Lytton, S.D.; Fischer, W.; Nagel, W.; Haas, R.; Beck, F.X. Production of ammonium by Helicobacter pylori mediates occluding processing and disruption of tight junctions in Caco-2 cells. Microbiology 2005, 155, 3267–3276. | pl_PL |
| dc.references | Backert, S.; Kwok, T.; Schmid, M.; Selbach, M.; Moese, S.; Peek, R.M., Jr.; König, W.; Meyer, T.F.; Jungblut, P.R. Subproteomes of soluble and structure-bound H. pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005, 5, 1311–3345. | pl_PL |
| dc.references | Cover, T.L.; Blanke, S.R.H. pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 2005, 3, 320–332. | pl_PL |
| dc.references | Palframan, S.L.; Kwok, T.; Gabriel, K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori. Front. Cell. Infect. Microbiol. 2012, 2, 92. | pl_PL |
| dc.references | Yahiro, K.; Satoh, M.; Nakano, M.; Hisatsune, J.; Isomoto, H.; Sap, J.; Suzuki, H.; Nomura, F.; Noda, M.; Moss, J.; et al. Low-density lipoprotein receptor-related protein-1 (LRP-1) mediates autophagy and apoptosis caused by H. pylori VacA. J. Biol. Chem. 2012, 287, 31104–31115. | pl_PL |
| dc.references | Hoy, B.; Löwer, M.; Weydig, C.; Carra, G.; Tegtmeyer, N.; Geppert, T.; Schröder, P.; Sewald, N.; Backert, S.; Schneider, G.; et al. H. pylori Htr is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010, 11, 798–804. | pl_PL |
| dc.references | Muotiala, A.; Helander, I.M.; Pyhälä, L.; Kosunen, T.U.; Moran, A.P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 1992, 60, 1714–1716. | pl_PL |
| dc.references | Moran, A.P.; Helander, I.M.; Kosunen, T.U. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 1992, 174, 1370–1377. | pl_PL |
| dc.references | Moran, A.P.; Aspinall, G.O. Unique structural and biological features of Helicobacter pylori lipopolysaccharides. Prog. Clin. Biol. Res. 1998, 397, 37–49. | pl_PL |
| dc.references | Appelmelk, B.J.; Simoons-Smit, I.; Negrini, R.; Moran, A.P.; Aspinall, G.O.; Forte, J.G.; DeVries, T.; Quan, H.; Verboom, T.; Maaskant, J.J.; et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 1996, 64, 2031–2040. | pl_PL |
| dc.references | Paziak-Doma ´nska, B.; Chmiela, M.; Jarosi ´nska, A.; Rudnicka, W. Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infection. Cell. Immunol. 2000, 202, 136–139. | pl_PL |
| dc.references | Grebowska, A.; Moran, A.P.; Bielanski, W.; Matusiak, A.; Rechcinski, T.; Rudnicka, K.; Szcz ˛esna, E.; Walencka, M.; Rudnicka, W.; Chmiela, M. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J. Physiol. Pharmacol. 2010, 61, 437–442. | pl_PL |
| dc.references | Grebowska, A.; Moran, A.P.; Matusiak, A.; Bak-Romaniszyn, L.; Czkwianianc, E.; Rechci ´nski, T.; Walencka, M.; Płaneta-Małecka, I.; Rudnicka, W.; Chmiela, M. Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS)-possible modulation of the innate immune response to these bacteria. Pol. J.Microbiol. 2008, 57, 185–192. | pl_PL |
| dc.references | . Chmiela, M.; Miszczyk, E.; Rudnicka, K. Structural modifications of Helicobacter pylori lipopolysaccharide: An idea for how to live in peace. World J. Gastroenterol. 2014, 20, 9882–9897. | pl_PL |
| dc.references | . Rudnicka, K.; Miszczyk, E.; Matusiak, A.; Walencka, M.; Moran, A.P.; Rudnicka, W.; Chmiela, M. Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity. Innate Immun. 2015, 21, 127–139. | pl_PL |
| dc.references | Miszczyk, E.; Walencka, M.; Rudnicka, K.; Matusiak, A.; Rudnicka, W.; Chmiela, M. Antigen-specific lymphocyte proliferation as a marker of immune response in guinea pigs with sustained Helicobacter pylori infection. Acta Biochim. Pol. 2014, 61, 295–303. | pl_PL |
| dc.references | Mnich, E.; Gajewski, A.; Rudnicka, K.; Gonciarz, W.; Stawerski, P.; Hinc, K.; Obuchowski, M.; Chmiela, M. Immunoregulation of antigen presenting and secretory functions of monocytic cells by Helicobacter pylori antigens in relation to impairment of lymphocyte expansion. Acta Biochim. Pol. 2015, 62, 641–650. | pl_PL |
| dc.references | Shi, Y.; Evans, J.E.; Rock, K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425, 516–521. | pl_PL |
| dc.references | Kono, H.; Rock, K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8, 279–298. | pl_PL |
| dc.references | Roussel, L.; Erard, M.; Cayrol, C.; Girard, J.P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 2008, 9, 1006–1012. | pl_PL |
| dc.references | L ˝uthi, A.U.; Cullen, S.P.; McNeela, E.A.; Duriez, O.P.J.; Afonina, I.S.; Sheridan, C.; Brumatti, G.; Taylor, R.C.; Kersse, K.; Vandenabeele, P.; et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31, 84–98. | pl_PL |
| dc.references | Ali, S.; Nguyen, D.Q.; Falk, W.; Martin, M.U. Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem. Biophys. Res. Commun. 2010, 91, 512–516. | pl_PL |
| dc.references | Millar, N.L.; O’Donnell, C.; McInnes, I.B.; Brint, E. The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis. Semin. Cell Dev. Biol. 2017, 61, 41–50. | pl_PL |
| dc.references | Ohno, T.; Oboki, K.; Morita, H.; Kajiwara, N.; Arae, K.; Tanaka, S.; Ikeda, M.; Likura, M.; Akiyama, T.; Inoue, J.; et al. Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS ONE 2011, 6, e18404. | pl_PL |
| dc.references | Ivanov, V.N.; Zhou, H.; Ghandhi, S.A.; Karasic, T.B.; Yaghoubian, B.; Amundson, S.A.; Hei, T.K. Radiation-induced bystander signaling pathways in human fibroblasts: A role for interleukin-33 in the signal transmission. Cell. Signal. 2010, 22, 1076–1087. | pl_PL |
| dc.references | Modofsky, A.B.; Savage, A.; Locksley, R.M. Interleukin-33 in tissue homeostasis, injury and inflammation. Immunity 2015, 42, 1005–1019. | pl_PL |
| dc.references | Espinassous, Q.; Garcia-de-Paco, E.; Garcia-Verdugo, I.; Synguelakis, M.; von Aulock, S.; Sallenave, J.M.; McKenzie, A.N.; Kanellopoulos, J. IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 2009, 183, 1446–1455. | pl_PL |
| dc.references | Caselli, C. Inflammation in cardiac disease: Focus on interleukin-33/ST2 pathway. Inflamm. Cell Signal. 2014, 1, 118–151. | pl_PL |
| dc.references | Miller, A.M. Role of IL-33 in inflammation and disease. J. Inflamm. 2011, 8, 22. | pl_PL |
| dc.references | Liu, X.; Hammel, H.; He, Y.; Tainer, J.A.; Jeng, U.S.; Zhang, L.; Wang, S.; Wang, S.; Wang, X. Structural insights into the interaction of IL-33 with its receptor. PNAS. 2013, 110, 14918–14923. | pl_PL |
| dc.references | Pastorelli, L.; De Salvo, C.; Vecchi, M.; Pizarro, T.T. The role of IL-33 in gut mucosal inflammation. Mediators Inflamm. 2013, 608187. | pl_PL |
| dc.references | Lopetuso, H.; Scaldaferri, F.; Pizarro, T.T. Emerging role of the interleukin (IL)-23/ST2 axis in gut mucosal wound healing and fibrosis. Fibrogenes. Tissue Repair. 2012, 5, 18–29. | pl_PL |
| dc.references | Jovanovic, I.; Radosavljevic, G.; Mitrovic, M.; Juranic, V.L.; McKenzie, A.N.; Arsenijevic, N.; Jonjic, S.; Lukic, M.L. ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma. Eur. J. Immunol. 2011, 41, 1902–1912. | pl_PL |
| dc.references | Kuroiwa, K.; Arai, T.; Okazaki, H.; Minota, S.; Tominaga, S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001, 284, 1104–1108. | pl_PL |
| dc.references | López-Casado, M.A.; Lorite, P.; Palomeque, T.; Torres, M.I. Potential role of the IL-33/ST2 axis in celiac disease. Cell. Mol. Immunol. 2015, 1, 282–285. | pl_PL |
| dc.references | Buzelli, J.N.; Chalinor, H.V.; Pavlic, D.I.; Sutton, P.; Menheniott, T.R.; Giraud, A.S.; Judd, L.M. IL-33 is a stomach alarmin that initiates a skewed Th2 response to injury and infection. Cell. Mol. Gastroenterol. Hepatol. 2015, 1, 203–221. | pl_PL |
| dc.references | Smith, M.F.; Mitchell, A.; Li, G.; Ding, S.; Fitzmaurice, A.M.; Ryan, K.; Crowe, S.; Goldberg, J.B. Toll-like receptor (TLR) 2 and TLR5 but not TLR4, are required for H. pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem 2003, 278, 32552–32560. | pl_PL |
| dc.references | Wang, J.X.; Kaiedaa, S.; Ameria, S.; Fishgala, N.; Dwyera, D.; Dellingerc, A.; Kepley, C.L.; Gurish, M.F.; Nigrovic, P.A. IL-33/ST2 axis promotes mast cell survival via BCLXL. Proc. Natl. Acad. Sci. USA. 2014, 11, 10281–10286. | pl_PL |
| dc.references | Gonciarz, W.; Walencka, M.; Moran, A.P.; Hinc, K.; Obuchowski, M.; Chmiela, M. Upregulation of MUC5AC production and deposition of Lewis determinants by Helicobacter pylori facilitate gastric tissue colonization and the maintenance of infection. J. Biomed. Sci. 2019, 26, 23. | pl_PL |
| dc.references | Gonciarz, W.; Krupa, A.; Hinc, K.; Obuchowski, M.; Moran, A.P.; Gajewski, A.; Chmiela, M. The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS ONE 2019, 14, e0220636. | pl_PL |
| dc.references | De Paulis, A.; Prevete, N.; Rossi, F.W.; Rivellese, F.; Salerno, F.; Delfino, G.; Liccardo, B.; Avilla, E.; Montuori, N.; Mascolo, M.; et al. Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo. J. Immunol. 2009, 183, 3761–3769. | pl_PL |
| dc.references | Lott, J.M.; Sumpter, T.L.; Turnquist, H.R. New dog and newtricks: Evolving roles for IL-33 in type 2 immunity. J. Leukoc. Biol. 2015, 97, 1037–1048. | pl_PL |
| dc.references | Hu, W.T.; Li, M.Q.; Liu, W.; Jin, L.P.; Li, D.J.; Zhu, X.Y. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-kB and ERK 1/2 signalling. Mol. Hum. Reprod. 2014, 20, 358–372. | pl_PL |
| dc.references | Seki, K.; Sanada, S.; Kudinova, A.Y.; Steinhauser, M.L.; Handa, V.; Gannon, J.; Lee, R.T. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ. Heart Fail. 2009, 2, 684–691. | pl_PL |
| dc.references | Oboki, K.; Ohno, T.; Kajiwara, N.; Saito, H.; Nakae, S. IL-33 and IL-33 receptors in host defense and diseases. Allergol. Int. 2010, 59, 143–160. | pl_PL |
| dc.references | Oboki, K.; Ohno, T.; Kajiwara, N.; Arae, K.; Morita, H.; Ishii, A.; Nambu, A.; Abe, T.; Kiyonari, H.; Matsumoto, K.; et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 2010, 107, 18581–18586. | pl_PL |
| dc.references | Matter, K.; Aijaz, S.; Tsapara, A.; Balda, M.S. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr. Opin. Cell Biol. 2005, 17, 453–458. | pl_PL |
| dc.references | Varbanova, M.; Frauenschläger, K.; Malfertheiner, P. Chronic gastritis—An update. Best Pract. Res. Clin. Gastroenterol. 2014, 28, 1031–1042. | pl_PL |
| dc.references | Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12, 991–1045. | pl_PL |
| dc.references | Carriere, V.; Roussel, L.; Ortega, N.; Lacorre, D.A.; Americh, L.; Aguilar, L.; Bouche, G.; Girard, J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA. 2007, 104, 282–287. | pl_PL |
| dc.references | Ramaro, N.; Meyer, T.F. Helicobacter pylori resists phagocytosis by macrophages: Quantitative assessment by confocal microscopy and fluorescence-activated cell sorting. Infect. Immun. 2001, 69, 2604–2611. | pl_PL |
| dc.references | Mnich, E.; Kowalewicz-Kulbat, M.; Sici ´nska, P.; Hinc, K.; Obuchowski, M.; Gajewski, A.; Moran, A.P.; Chmiela, M. Impact of Helicobacter pylori on the healing process of the gastric barrier. World J. Gastroenterol. 2016, 22, 7536–7558. | pl_PL |
| dc.references | Viladomiu, M.; Bassaganya-Riera, J.; Tubau-Juni, N.; Kronsteiner, B.; Leber, A.; Philipson, C.W.; Zoccoli-Rodriguez, V.; Hontecillas, R. Cooperation of gastric mononuclear phagocytes with Helicobacter pylori during colonization. J. Immunol. 2017, 198, 3195–3204. | pl_PL |
| dc.references | Krzysiek-Maczka, G.; Targosz, A.; Ptak-Belowska, A.; Korbut, E.; Szczyrk, U.; Strzalka, M.; Brzozowski, T. Molecular alterations in fibroblasts exposed to Helicobacter pylori: A missing link in bacterial inflammation progressing into gastric carcinogenesis? J. Physiol. Pharmacol. 2013, 64, 77–87. | pl_PL |
| dc.references | Yi, L.; Huang, X.; Guo, F.; Zhou, Z.; Chang, M.; Tang, J.; Huan, J. Lipopolysaccharide induces human pulmonary micro-vascular endothelial apoptosis via the YAP signaling pathway. Front. Cell. Infect. Microbiol. 2016, 6, 133. | pl_PL |
| dc.references | Gajewski, A.; Gonciarz, W.; Hinc, K.; Obuchowski, M.; Chmiela, M. Dysfunction of gastric barrier in the milieu of 7-ketocholesterol, acetylsalicylic acid and Helicobacter pylori compounds. Potential implications in the development of coronary heart disease. Helicobacter. 2018, 23 (Suppl. S1), 65. | pl_PL |
| dc.references | Shibata, J.; Goto, H.; Arisawa, T.; Niwa, Y.; Hayakawa, T.; Nakayama, A.; Mori, N. Regulation of tumor necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut. 1999, 45, 24–31. | pl_PL |
| dc.references | Walencka, M.; Gonciarz, W.; Mnich, E.; Gajewski, A.; Stawerski, P.; Knapik-Dabrowicz, A.; Chmiela, M. The microbiological, histological, immunological and molecular determinants of Helicobacer pylori infection in guinea pigs as a convenient animal model to study pathogenicity of these bacteria and the infection dependent immune response of the host. Acta Biochim. Pol. 2015, 62, 697–706. | pl_PL |
| dc.references | Rechci ´nski, T.; Chmiela, M.; Małecka-Panas, E.; Płaneta-Małecka, I.; Rudnicka, W. Serological indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors. Microbiol. Immunol. 1997, 41, 387–393. | pl_PL |
| dc.references | Czkwianianc, E.; Chmiela, M.; Lawnik, M.; Płaneta-Małecka, I.; Rudnicka, W. Serodiagnosis of Helicobacter pylori in children with gastroduodenitis. Centr. Eur. J. Immunol. 1997, 22, 240–247. | pl_PL |
| dc.references | Jensen, E.C. Quantitative analysis of histological staining and fluorescence using image. Anat. Rec. 2013, 3, 378–381. | pl_PL |
| dc.contributor.authorEmail | magdalena.chmiela@biol.uni.lodz.pl | pl_PL |
| dc.identifier.doi | https://doi.org/10.3390/ijms21051801 | |
| dc.discipline | nauki biologiczne | pl_PL |
Pliki tej pozycji
Pozycja umieszczona jest w następujących kolekcjach
Poza zaznaczonymi wyjątkami, licencja tej pozycji opisana jest jako Uznanie autorstwa 4.0 Międzynarodowe